Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

NCT02743351

Conditions
Acute Graft-versus-host Disease, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +35 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of California, San Diego (UCSD) Moores Cancer Center San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT03476239

Conditions
Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Chinese People Liberation Army General Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
View all 23 locations
View Trial Details
Completed

Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL

NCT04030195

Conditions
B-cell Chronic Lymphocytic Leukemia, B-cell Non Hodgkin Lymphoma, Chronic Disease, +25 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University Stanford, California, United States
  • Columbia University New York, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

NCT01607892

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +35 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Completed

Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL

NCT02758665

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Universitätsklinikum Köln Cologne, Germany
  • BAG Onkologische Gemeinschaftspraxis Dresden, Germany
  • Universitätsklinikum Essen Essen, Germany
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Germany
View Trial Details
Completed

Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia

NCT03374137

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • Inje University Busan Paik Hospital; Hematology-oncology Busan, South Korea
  • Pusan National University Hospital Busan, South Korea
  • St. Vincent's Hospital Gyeonggi-do, South Korea
  • Hallym University Sacred Heart Hospital; Department of Hematology Gyeonggi-do, South Korea
View all 17 locations
View Trial Details

Related conditions